These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23794363)
1. A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease. Multhammer M; Michels A; Zintl M; Mendoza MC; Klünemann HH Acta Neurol Belg; 2014 Mar; 114(1):25-31. PubMed ID: 23794363 [TBL] [Abstract][Full Text] [Related]
2. Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms. Michels A; Multhammer M; Zintl M; Mendoza MC; Klünemann HH J Alzheimers Dis; 2012; 28(1):25-32. PubMed ID: 22246233 [TBL] [Abstract][Full Text] [Related]
3. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. Tröster AI; Fields JA; Paolo AM; Koller WC J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
6. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187 [TBL] [Abstract][Full Text] [Related]
7. Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E ε4 allele in a sample of Bulgarian patients with late-onset Parkinson's disease. Pavlova R; Mehrabian S; Petrova M; Skelina S; Mihova K; Jordanova A; Mitev V; Traykov L Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):614-9. PubMed ID: 24646656 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength. Batterham PJ; Bunce D; Cherbuin N; Christensen H Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos. Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760 [TBL] [Abstract][Full Text] [Related]
10. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Klages JD; Fisk JD; Rockwood K Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction. Bleumink GS; van Duijn CM; Kingma JH; Witteman JC; Hofman A; Stricker BH Am Heart J; 2004 Apr; 147(4):685-9. PubMed ID: 15077085 [TBL] [Abstract][Full Text] [Related]
12. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study. Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM; Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224 [TBL] [Abstract][Full Text] [Related]
13. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population. López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455 [TBL] [Abstract][Full Text] [Related]
15. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [TBL] [Abstract][Full Text] [Related]
16. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele. Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Zareparsi S; Kaye J; Camicioli R; Grimslid H; Oken B; Litt M; Nutt J; Bird T; Schellenberg G; Payami H Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478 [TBL] [Abstract][Full Text] [Related]
18. Distribution of APOE genotypes in a memory clinic cohort. van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171 [TBL] [Abstract][Full Text] [Related]
19. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528 [TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]